Leonard JP - Search Results

1

Where to start? Upfront therapy for follicular lymphoma in 2018.

Leonard JP, Nastoupil LJ, Flowers CR. Leonard JP, et al. Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):185-188. doi: 10.1182/asheducation-2018.1.185. Hematology Am Soc Hematol Educ Program. 2018. PMID: 30504308 Free PMC article. Review.

2

Immunotherapy of Non-Hodgkin's lymphomas.

Press OW, Leonard JP, Coiffier B, Levy R, Timmerman J. Press OW, et al. Among authors: leonard jp. Hematology Am Soc Hematol Educ Program. 2001:221-40. doi: 10.1182/asheducation-2001.1.221. Hematology Am Soc Hematol Educ Program. 2001. PMID: 11722986 Review.

3

Immunotherapy of non-Hodgkin's lymphoma with hLL2 (epratuzumab, an anti-CD22 monoclonal antibody) and Hu1D10 (apolizumab).

Leonard JP, Link BK. Leonard JP, et al. Semin Oncol. 2002 Feb;29(1 Suppl 2):81-6. Semin Oncol. 2002. PMID: 11842393 Review.

4

Phase I/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin's lymphoma.

Leonard JP, Coleman M, Ketas JC, Chadburn A, Ely S, Furman RR, Wegener WA, Hansen HJ, Ziccardi H, Eschenberg M, Gayko U, Cesano A, Goldenberg DM. Leonard JP, et al. J Clin Oncol. 2003 Aug 15;21(16):3051-9. doi: 10.1200/JCO.2003.01.082. Epub 2003 Jul 1. J Clin Oncol. 2003. PMID: 12837807 Clinical Trial.

5

CD22-directed monoclonal antibody therapy for lymphoma.

Siegel AB, Goldenberg DM, Cesano A, Coleman M, Leonard JP. Siegel AB, et al. Among authors: leonard jp. Semin Oncol. 2003 Aug;30(4):457-64. doi: 10.1016/s0093-7754(03)00240-9. Semin Oncol. 2003. PMID: 12939714 Review.

6

Epratuzumab: targeting B-cell malignancies through CD22.

Coleman M, Goldenberg DM, Siegel AB, Ketas JC, Ashe M, Fiore JM, Leonard JP. Coleman M, et al. Among authors: leonard jp. Clin Cancer Res. 2003 Sep 1;9(10 Pt 2):3991S-4S. Clin Cancer Res. 2003. PMID: 14506198 Review.

7

Combination antibody therapy with epratuzumab and rituximab in relapsed or refractory non-Hodgkin's lymphoma.

Leonard JP, Coleman M, Ketas J, Ashe M, Fiore JM, Furman RR, Niesvizky R, Shore T, Chadburn A, Horne H, Kovacs J, Ding CL, Wegener WA, Horak ID, Goldenberg DM. Leonard JP, et al. J Clin Oncol. 2005 Aug 1;23(22):5044-51. doi: 10.1200/JCO.2005.13.821. Epub 2005 Jun 13. J Clin Oncol. 2005. PMID: 15955901 Clinical Trial.

8

New developments in immunotherapy for non-Hodgkin's lymphoma.

Leonard JP, Furman RR, Ruan J, Coleman M. Leonard JP, et al. Curr Oncol Rep. 2005 Sep;7(5):364-71. doi: 10.1007/s11912-005-0063-4. Curr Oncol Rep. 2005. PMID: 16091197 Review.

9

Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma.

Leonard JP, Coleman M, Kostakoglu L, Chadburn A, Cesarman E, Furman RR, Schuster MW, Niesvizky R, Muss D, Fiore J, Kroll S, Tidmarsh G, Vallabhajosula S, Goldsmith SJ. Leonard JP, et al. J Clin Oncol. 2005 Aug 20;23(24):5696-704. doi: 10.1200/JCO.2005.14.803. J Clin Oncol. 2005. PMID: 16110029 Clinical Trial.

10

Antibodies in the treatment of lymphoma.

Leonard JP. Leonard JP. Clin Adv Hematol Oncol. 2004 Apr;2(4):210-1. Clin Adv Hematol Oncol. 2004. PMID: 16163182 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters